ADVERSE EVENT
Clinical trials for ADVERSE EVENT explained in plain language.
Never miss a new study
Get alerted when new ADVERSE EVENT trials appear
Sign up with your email to follow new studies for ADVERSE EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs shows promise against rare lymphoma
Disease control Not yet recruitingThis study is testing a combination of three drugs—sintilimab, chidamide, and azacitidine—as a first treatment for people with early-stage extranodal NK/T-cell lymphoma, a rare blood cancer. About 30 participants will receive the drugs, and their response will guide further treat…
Matched conditions: ADVERSE EVENT
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New app aims to prevent medication mishaps during flu season
Knowledge-focused Not yet recruitingThis pilot study tests a mobile app called PAUSE that helps people with chronic conditions like diabetes or heart disease know which medications to pause when they get sick. About 320 patients from 16 pharmacies in Alberta will use the app or receive standard guidance. The goal i…
Matched conditions: ADVERSE EVENT
Phase: NA • Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC